We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

BioLineRx Announces Investigator-Initiated Study for Novel CML Treatment

News   Apr 12, 2014

 
BioLineRx Announces Investigator-Initiated Study for Novel CML Treatment
 
 
 

RELATED ARTICLES

3D Protein Structure Aids Anti-cancer Drug Design

News

A research team has discovered a new mechanism for a class of anti-cancer drugs known as E1 inhibitors. Their findings reveal a novel binding site that will promote drug design of more efficient E1 inhibitors.

READ MORE

Sparing Sensitive Organs from Radiation Damage to Reduce Side Effects

News

A new way to plan radiotherapy could help shape treatment away from sensitive organs near tumors to reduce side-effects, a new study shows.

READ MORE

CRISPR Engineered “Invisible” Immune Cells

News

scientists have used the CRISPR-Cas9 gene-editing system to create the first pluripotent stem cells that are functionally "invisible" to the immune system, a feat of biological engineering that, in laboratory studies, prevented rejection of stem cell transplants.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE